⚡ Quick Start — If You Read Nothing Else
The 10 most important things to know about normal pressure hydrocephalus (NPH).
- NPH is one of the few potentially reversible causes of dementia. It is caused by a buildup of cerebrospinal fluid (CSF) in the brain's chambers (ventricles), and in the right person, surgery to drain that fluid can improve symptoms — sometimes dramatically. This is the central reason for hope.
- It has a classic trio of symptoms (the “Hakim triad”): trouble walking, thinking changes, and bladder problems. A memorable shorthand is “wet, wacky, and wobbly,” though most people do not have all three equally, and the order varies.
- Walking trouble is usually the first and most important symptom — and the most likely to improve with treatment. The gait is often described as slow, broad-based, shuffling, or “magnetic” (feet feeling stuck to the floor).
- It is frequently missed or mistaken for Alzheimer's, Parkinson's, or “just aging.” Because it is treatable, it is worth specifically considering — especially when walking problems are prominent.
- The diagnosis combines brain imaging with a fluid test. An MRI shows enlarged ventricles, and a “tap test” (removing some spinal fluid and seeing if walking improves) helps predict whether surgery will help.
- The main treatment is a shunt — a thin tube that drains excess fluid from the brain to the abdomen. Modern shunts have adjustable valves that can be fine-tuned without surgery.
- A 2025 placebo-controlled trial (PENS) confirmed that shunting genuinely improves walking — but it also showed that thinking and bladder symptoms improve less reliably, so realistic expectations matter.
- Not everyone is a candidate, and surgery has real risks (bleeding, infection, over- or under-draining). Careful selection — especially a good response to the tap test — gives the best odds of benefit.
- Other conditions often coexist. Many people with NPH also have some Alzheimer's-type or vascular changes, which can limit how much thinking improves even when walking gets better.
- Act sooner rather than later. Treating NPH before symptoms are severe and long-standing tends to give better results, so prompt evaluation by a specialist matters.
Understanding Normal Pressure Hydrocephalus
If you or a loved one has been told there might be “water on the brain” or normal pressure hydrocephalus, the news can be confusing — but it also carries something unusual and hopeful: this is one of the few causes of dementia and walking decline that may be reversible with treatment. This guide explains, in plain language, what NPH is, how it is diagnosed, what surgery can (and cannot) do, and how to navigate the decision — organized by where you are in the journey.
Normal pressure hydrocephalus (NPH) is a condition in which cerebrospinal fluid — the clear fluid that cushions the brain — builds up in the brain's fluid chambers (the ventricles), enlarging them and stretching nearby brain tissue. The “normal pressure” in the name means that, despite the buildup, the pressure measured by a routine spinal tap is usually in the normal range, which is part of why it can be tricky to recognize. Most cases are idiopathic (iNPH), meaning no clear cause is found; it mainly affects people in their 60s, 70s, and beyond.
Telling NPH apart from “normal aging”
It is easy to dismiss the early signs of NPH as ordinary aging, which is part of why it is missed. A few features should raise suspicion and prompt evaluation: a walking problem that is out of proportion to any arthritis or weakness, that is symmetric (both legs), and that has a distinctive shuffling, wide, or “stuck-to-the-floor” quality; thinking changes that are more about mental slowing and difficulty with attention and planning than dense memory loss; and the combination of these with new urinary urgency. The gradual onset over months, the prominence of walking trouble, and enlarged ventricles on a scan together point toward NPH rather than simple aging. Because the stakes — a potentially treatable condition — are high, it is reasonable to ask specifically, “Could this be NPH?”
The Hakim triad: the classic three symptoms
NPH classically causes three kinds of problems, though people rarely have all three to the same degree:
- Gait (walking) disturbance — usually the first and most prominent symptom. Walking becomes slow, unsteady, broad-based, and shuffling; people often describe feeling as if their feet are “stuck to the floor” (a “magnetic” gait), with difficulty turning and a tendency to fall.
- Cognitive (thinking) changes — typically slowed thinking, trouble with attention, planning, and memory retrieval (a “frontal-subcortical” pattern), rather than the dense forgetfulness of early Alzheimer's.
- Urinary symptoms — urgency and frequency at first, progressing to incontinence (loss of control) in more advanced cases.
The memorable phrase “wet, wacky, and wobbly” captures the trio — but the most important practical point is that walking problems usually lead, and respond best to treatment.
A little more detail on each helps you and your family recognize and describe them. The gait change is distinctive: short, shuffling steps with feet placed wide apart, difficulty starting to walk and turning (often taking many small steps to turn), and a feeling of being unsteady or pulled backward — quite different from the limp of a bad hip or knee. The cognitive change is usually a slowing and “effortfulness” of thinking, trouble concentrating, planning, and keeping track of tasks, and slowed responses — people often still recognize family and places, unlike in advanced Alzheimer's. The urinary change starts as needing to go often and urgently and can progress to leaking or loss of control. Describing which of these you have, and especially documenting the walking, gives your medical team the clearest path to the diagnosis.
Why getting this right matters so much
Among the causes of progressive walking and thinking decline in older adults, NPH stands out for a simple reason: it can be treated, and the treatment can restore function. That makes recognizing it genuinely important — a person whose unsteady walking and slowed thinking are quietly attributed to “getting older,” Alzheimer's, or Parkinson's may be missing a treatable diagnosis. At the same time, the flip side matters too: not everyone with enlarged ventricles has treatable NPH, and surgery has real risks, so careful evaluation protects people from operations unlikely to help. The goal of a good workup is to find the people who will truly benefit and steer them toward treatment, while sparing those who would not. This balance — hopeful about a treatable condition, honest about who it helps — runs through this entire guide.
Why it happens
The brain constantly makes and reabsorbs CSF. In NPH, the balance is disturbed — the fluid is not reabsorbed efficiently — so it accumulates and enlarges the ventricles, pressing on the nearby nerve pathways that control the legs, bladder, and aspects of thinking. In idiopathic NPH the precise cause is unknown, and it may be related to changes in blood vessels and CSF dynamics with aging. Secondary NPH can follow a prior brain hemorrhage, meningitis, or head injury. Because the affected pathways can sometimes recover when the pressure on them is relieved, draining the fluid can improve symptoms — the basis of treatment.
Who develops NPH
NPH mainly affects older adults, typically over 60, and becomes more common with age. It is thought to be under-recognized: because its symptoms overlap with other common conditions of aging — Alzheimer's disease, Parkinson's disease, arthritis, and ordinary frailty — it is frequently missed or misattributed. Estimates suggest a meaningful fraction of people with unexplained gait and cognitive decline in later life may have NPH that could benefit from evaluation.
The practical consequence of this under-recognition is real and avoidable. Many people with NPH spend months or years being treated for “arthritis,” given a presumptive label of Alzheimer's, or simply told their decline is age, while a potentially reversible condition goes unaddressed — and falls, loss of independence, and caregiver strain accumulate in the meantime. The flip side is equally important: enlarged ventricles on a scan are common in older adults and do not by themselves mean treatable NPH, so not everyone with an “NPH-looking” scan should have surgery. The path between these errors is a proper evaluation by clinicians experienced in NPH. If walking trouble is prominent and unexplained, it is reasonable and worthwhile to ask directly whether NPH should be considered and tested for.
Common questions, honest answers
- “Is NPH really reversible?” It can be improved, sometimes a lot — especially walking — in the right person with a shunt. It is not a guaranteed “cure,” and thinking and bladder symptoms respond less reliably, but it is one of the few causes of dementia and gait decline where treatment can genuinely turn things around.
- “My MRI shows big ventricles — do I have NPH?” Not necessarily. Ventricles enlarge with normal aging and other conditions too. NPH is suggested by the disproportion on imaging plus the right symptoms, and is best confirmed by improvement when fluid is removed (the tap test).
- “Is this just old age or Alzheimer's?” It is often mistaken for both, which is exactly why it is worth specifically checking — because, unlike those, it may be treatable. Prominent walking trouble is a clue that points toward NPH.
- “Will a shunt fix my memory?” Maybe partly, but walking is the symptom most likely to improve. The 2025 PENS trial confirmed the walking benefit but did not show a clear short-term memory benefit, so it is best to expect the most for gait.
- “Am I too old for surgery?” Age alone usually is not the deciding factor — overall health and the likelihood of benefit (especially a good tap-test response) matter more. Many older adults do well.
- “What if I don't have the surgery?” NPH tends to worsen gradually, raising the risk of falls and loss of independence. If surgery is not chosen, care focuses on safety, rehabilitation, and managing symptoms.
Questions to ask your doctor
- Could my (or my loved one's) symptoms be due to normal pressure hydrocephalus?
- Does my MRI show enlarged ventricles, and are they out of proportion to normal aging?
- Should I have a tap test to see whether I might respond to a shunt?
- How prominent is my walking problem compared with thinking and bladder symptoms?
- Who is the right specialist (neurology, neurosurgery) to evaluate me?
Diagnosis
Diagnosing NPH well is crucial, because it determines who is likely to benefit from surgery. It combines the clinical picture, brain imaging, and — importantly — tests that predict response to draining fluid.
The clinical picture
Diagnosis starts with recognizing the pattern: an older adult with an unexplained, symmetric walking disturbance, a frontal-subcortical pattern of thinking changes, and/or urinary urgency, whose other conditions do not fully explain the symptoms. A careful neurologic exam, with close attention to gait (often timed and videotaped to compare later), and cognitive testing, are the foundation.
What the office evaluation involves
The first visits usually combine a careful history with a focused examination. Your clinician will ask when each symptom started and how it has changed, with particular attention to the timeline of the walking problem relative to thinking and bladder changes, and to anything that might point to another cause. The exam includes watching you walk — often timing it and noting the stride width, shuffling, turning, and balance — and brief cognitive testing of attention, memory, and problem-solving. A bladder history is taken. A close family member's account is invaluable, since they often notice the gradual changes and falls most clearly. There is no need to prepare in any special way, but it helps to bring a list of your medicines, a summary of when symptoms began, and, if possible, a short video of the walking difficulty. From this picture, your clinician decides which tests — imaging and a tap test — will best answer whether this is treatable NPH.
Brain imaging
An MRI (or CT) of the brain is essential. In NPH it shows enlarged ventricles out of proportion to brain shrinkage — measured in part by the “Evans index.” Radiologists also look for a specific pattern called DESH (disproportionately enlarged subarachnoid space hydrocephalus) and a narrowed “callosal angle,” both of which support the diagnosis and help predict who will respond to a shunt. Imaging also helps rule out other causes such as strokes, tumors, or a blockage.
It helps to understand what the scan can and cannot tell you. The MRI is excellent at showing the structure — how large the ventricles are, the patterns (like DESH and the callosal angle) that favor NPH, and signs of other problems such as strokes or a blockage. What it cannot do by itself is prove that draining fluid will help you, because some people with NPH-like scans do not respond to a shunt, and some people with less dramatic scans do. That is why imaging is paired with the response to removing fluid (the tap test or drainage trial). Think of the scan as identifying who is a plausible candidate, and the fluid-removal test as showing who is likely to actually benefit — together they guide a careful, individualized decision.
How walking is measured
Because gait is the key symptom — both for diagnosis and for predicting and judging treatment response — doctors measure it carefully and objectively rather than relying on impressions. You may be asked to walk a set distance (such as 10 meters) while it is timed, or to do a “timed up-and-go” (rise from a chair, walk a few meters, turn, return, sit), and the number of steps and turning may be counted. These walks are often videotaped so the team can compare your gait before and after fluid is removed, and before and after surgery. This objectivity matters: a clear, measured improvement in walking speed after a tap test is one of the strongest signs that a shunt will help, and it guards against being misled by hopeful but subjective impressions on either side.
The tap test and drainage trials
The single most useful predictor of whether surgery will help is seeing what happens when fluid is removed:
- The tap test (large-volume lumbar puncture): a doctor removes a substantial amount of CSF through a needle in the lower back (local anesthetic), and your walking (and sometimes thinking) is measured before and after, usually over a day or two. A clear improvement in gait strongly suggests a shunt will help.
- Extended lumbar drainage: if the tap test is inconclusive, a thin catheter may be left in place for a few days in the hospital to drain fluid continuously, giving a more sensitive test of response.
- Infusion or pressure studies are used in some centers to assess CSF dynamics.
A good response to these tests is reassuring and improves the odds that surgery will help; a poor response does not always rule out benefit but lowers the likelihood, and is weighed carefully.
Questions to ask your doctor
- What does my MRI show — are the ventricles enlarged out of proportion, and is there a DESH pattern?
- Should I have a tap test or extended lumbar drainage to predict shunt response?
- How will you measure whether my walking improves after fluid is removed?
- Have other causes (Alzheimer's, Parkinson's, stroke, spinal problems) been considered?
Treatment
The main treatment for NPH is surgical: placing a shunt to drain excess fluid. Understanding what it involves, what it can realistically achieve, and its risks helps you make a confident, informed decision.
The shunt
A ventriculoperitoneal (VP) shunt is a thin, soft tube placed by a neurosurgeon. One end sits in a ventricle of the brain; the tube runs under the skin to the abdomen, where the excess CSF drains and is harmlessly absorbed. A valve controls the flow. Modern adjustable (programmable) valves can be re-set non-invasively (with a magnetic device in the clinic) to fine-tune drainage — increasing it if symptoms persist, or decreasing it to prevent over-drainage. (A lumboperitoneal shunt, draining from the lower spine, is an alternative in some cases.)
How the shunt helps — and its limits
The logic of a shunt is straightforward: NPH symptoms come from excess fluid stretching and pressing on the brain pathways for the legs, bladder, and aspects of thinking; draining that fluid relieves the pressure, and those pathways can recover function. That is why walking, which depends on pathways especially affected by the enlarged ventricles, tends to improve the most. The limits come from two sources. First, if pathways have been compressed for a very long time or are severely damaged, recovery may be incomplete — an argument for not waiting too long. Second, many older adults also have other brain conditions (especially Alzheimer's-type changes) that a shunt cannot treat; when those contribute heavily to the thinking problems, memory may improve little even as walking gets better. Understanding this helps set realistic, domain-by-domain expectations rather than hoping a shunt will reverse everything.
Why the PENS trial matters
For years, doubts lingered about whether shunting truly worked for NPH or whether improvements were placebo effects or natural fluctuation — in part because earlier studies could not ethically use a true sham surgery. The PENS trial cleverly addressed this: everyone received the shunt operation, but the adjustable valve was set either to genuinely drain fluid (“open”) or, in the comparison group, to a setting so high it effectively did not drain (a “placebo” setting) — and neither patients nor assessors knew which. This rigorous design showed that the people with truly working shunts had real, measurable improvement in walking, while thinking and bladder scores were not clearly better than the placebo setting in the short term. The takeaway is reassuring and clarifying: shunting genuinely helps gait in well-selected patients, and it is honest to expect the most benefit there. It is among the strongest pieces of evidence in the field and underpins modern, realistic counseling.
What to expect, and what the evidence shows
Walking often improves first and most, sometimes within days to weeks; cognition and bladder symptoms may improve more variably and gradually. The landmark PENS trial (2025) — a rigorous study comparing a working shunt to a “placebo” (effectively switched-off) valve setting — confirmed that an open shunt genuinely improves gait, while improvements in thinking (MoCA) and bladder symptoms were not clearly better than placebo in that short-term study. The practical message: expect the most reliable benefit in walking, hope for but do not assume improvement in thinking and bladder, and understand that comorbid conditions (like Alzheimer's changes) can limit cognitive gains.
What the surgery and hospital stay involve
Shunt placement is a relatively short operation done under general anesthesia by a neurosurgeon. The surgeon makes a small opening in the skull to pass the upper end of the tube into a ventricle, tunnels the tubing under the skin down to the abdomen, and places the valve (usually behind the ear). Most people stay in the hospital a short time and recover from the operation itself fairly quickly. In the days and weeks afterward, the team checks the incision sites and the shunt, watches for over- or under-draining, and may adjust the valve setting in the clinic. Walking often begins to improve in the first weeks, and physical therapy helps you regain strength and confidence after what may have been a long period of unsteadiness. It is normal to have follow-up imaging and several visits as the valve is fine-tuned to your response.
Risks of surgery
Shunt surgery is generally safe but has real risks that must be weighed: bleeding around the brain (including subdural hematoma, more likely with over-drainage), infection, shunt blockage or malfunction (which may require revision), over-drainage (causing headaches, especially when upright) or under-drainage (persistent symptoms), and the usual risks of surgery and anesthesia. The PENS trial found more bleeding and positional headaches in the actively-shunted group — but also more falls in the placebo group, reflecting untreated gait problems. Adjustable valves help manage over- and under-drainage by allowing fine-tuning afterward.
When other conditions are also present
It is common for an older adult to have NPH and some degree of Alzheimer's-type or blood-vessel-related brain changes at the same time — the brain can have more than one thing going on. This matters for setting expectations: when these other conditions contribute significantly to the thinking problems, a shunt may improve walking nicely while memory improves only a little. It does not usually mean a shunt is pointless — regaining safer, more independent walking and reducing falls is genuinely valuable on its own. Your team may evaluate for these coexisting conditions (sometimes with additional tests) to give you a clearer picture of what to expect. The honest framing is: treat the treatable NPH component for the real benefits it offers, especially to walking, while understanding and separately addressing whatever else is contributing.
Living with a shunt
A shunt is a permanent, generally low-maintenance implant, and most people live normally with one. A few practical points help: the valve and tubing are under the skin and usually not visible or bothersome, and you can resume normal activities as your team advises after recovery. If you have an adjustable (programmable) valve, strong magnetic fields — including MRI scanners — can sometimes change its setting, so always tell any clinician (especially before an MRI) that you have a programmable shunt, and your team will check and reset the valve afterward if needed. Keep a record of your shunt and valve model. Over the years, shunts can occasionally block, disconnect, or need the valve re-adjusted, so report any return of symptoms or new headaches and keep your follow-up appointments. Knowing the signs of a shunt problem — and that they are treatable — lets you live confidently rather than anxiously with the device.
Who is a good candidate
The best candidates typically have prominent gait problems, a clear improvement after the tap test or lumbar drainage, supportive imaging, symptoms that are not too long-standing or severe, and limited competing conditions. Careful selection by an experienced team is what separates good outcomes from disappointment. Being older is not by itself a barrier; overall health and the likelihood of benefit matter more.
Questions to ask your doctor
- Based on my tap test and imaging, how likely am I to benefit from a shunt?
- Which symptoms are most likely to improve — and which may not?
- What are the specific risks in my case, and how experienced is the surgical team?
- Will I have an adjustable valve, and how is it managed afterward?
- What happens if the shunt does not help or causes problems?
Living with NPH, Recovery & Trials
Whether or not you have surgery, attention to safety, rehabilitation, and follow-up makes a real difference. Here is what to expect and how research is advancing.
The overall outlook
Putting it together, the outlook in NPH is genuinely more hopeful than for most causes of late-life cognitive and walking decline, with important caveats. For a person carefully selected — prominent walking trouble, a clear response to the tap test, supportive imaging, and not too much competing disease — a shunt can restore safer, more independent walking and reduce falls, sometimes dramatically, and this benefit has now been confirmed in a rigorous placebo-controlled trial. Thinking and bladder symptoms may improve too, but less reliably, and coexisting conditions can limit the cognitive gains. Surgery carries real but generally manageable risks, and the shunt is a lifelong device needing follow-up. For those who are not candidates, an active supportive plan still protects quality of life. The single most important message is that NPH is worth recognizing and evaluating, because for the right person, it is one of the rare treatable causes of these symptoms — and acting earlier tends to work better.
After a shunt: recovery and follow-up
Recovery from shunt surgery is usually quick, but the benefit to walking can continue to develop over weeks. Physical therapy helps rebuild strength, balance, and confidence after what may have been a long period of unsteady walking. Expect regular follow-up to check the shunt, possibly adjust the valve, and monitor for over- or under-drainage (report new or positional headaches, increasing confusion, or worsening symptoms). Shunts can need adjustment or, occasionally, revision over time, so ongoing specialist care is part of the plan.
The role of rehabilitation
Surgery removes the obstacle to better walking, but rehabilitation is often what turns that potential into real-world function. After months or years of unsteady, cautious walking, muscles weaken, balance reflexes get rusty, and fear of falling can itself limit movement. Physical therapy after a shunt — and sometimes before, to optimize starting condition — rebuilds strength, balance, and confidence, and teaches safe strategies for turning, standing, and navigating obstacles. Occupational therapy helps with daily tasks and home safety. Because the gait improvement from a shunt can keep developing over weeks, pairing it with consistent therapy gives the best functional result. Ask your team for a referral and a plan, and approach recovery as an active process rather than waiting passively for the shunt to “do everything.”
If surgery is not chosen
If you are not a candidate for surgery, or choose not to have it, care focuses on safety and quality of life: fall prevention (physical therapy, home safety, mobility aids), managing bladder symptoms, supporting thinking and daily function, and treating any coexisting conditions. Repeated spinal taps are not an effective long-term treatment, and no medication reliably treats NPH, so the focus is supportive.
Choosing not to have surgery is a legitimate decision, especially when the likelihood of benefit is uncertain, surgical risks are high, or it does not fit a person's goals — and it does not mean nothing can be done. A strong, active supportive plan can meaningfully protect quality of life: a physical therapy program to maintain strength and reduce falls, the right mobility aids, a home-safety review, sensible management of urinary urgency, and attention to treating other conditions (vascular risk, mood, sleep) that affect function. It is also reasonable to revisit the surgical question over time, because candidacy can change — for example, if walking trouble becomes more clearly the dominant problem. The key is that “no surgery” should still mean “active, thoughtful care,” not being left without support.
If the shunt doesn't seem to help
Sometimes a shunt does not produce the hoped-for improvement, and it is important to know this is not necessarily the end of the road. The first step is to make sure the shunt is actually working — it can be blocked, disconnected, or set at a pressure that is draining too little, all of which are checkable and often fixable (an adjustable valve can be re-set in the clinic, or imaging can look for a problem). If the shunt is working well but symptoms persist, it may mean that coexisting conditions (like Alzheimer's or vascular disease) are driving the symptoms, or that the disease was too advanced to fully reverse. Your team will work through these possibilities methodically. So before concluding a shunt “failed,” ask whether it is functioning correctly and whether the valve setting should be adjusted — a simple change sometimes unlocks the benefit.
What to expect over time
Untreated, NPH tends to progress gradually, with worsening walking, thinking, and bladder control and an increasing risk of falls and loss of independence. Treated successfully, many people regain meaningful function, especially walking — though coexisting conditions and the durability of benefit vary, and some improvement can fade over years. This is why timely diagnosis and treatment, before symptoms become severe and entrenched, generally give the best results.
A realistic picture of the long term: after a successful shunt, the early gains in walking are often the most noticeable, and continued physical therapy helps cement them. Over the following years, several things can influence how things go — the shunt itself can occasionally block or need its valve adjusted (so ongoing follow-up matters), and any coexisting conditions like Alzheimer's or vascular disease continue on their own course and can gradually affect thinking even if the NPH component is well treated. None of this means a shunt “wears off” for everyone; many people maintain meaningful benefit. But it does mean NPH care is ongoing rather than one-and-done, and that keeping up with follow-up, rehabilitation, and overall brain and vascular health gives the best long-term outcome.
Falls: a central, preventable risk
Falls deserve special attention in NPH because the walking problem makes them common, and a serious fall (a hip fracture or head injury) can be devastating — sometimes more immediately harmful than the underlying condition. Whether or not surgery is planned, fall prevention is a priority: a physical therapy assessment for balance and strength, appropriate use of a cane or walker (fitted and trained, not improvised), removing home hazards (loose rugs, clutter, poor lighting), installing grab bars and railings, sensible footwear, and managing the urinary urgency that prompts rushed, risky trips to the bathroom. Treating NPH successfully often reduces falls by improving gait, but in the meantime — and for those who do not have surgery — these practical measures protect against one of the condition's most dangerous consequences.
>Clinical trials and research
Research in NPH is active, focused on better predicting who will benefit and refining surgery:
- The PENS trials (the pilot, NCT03350750, and the larger efficacy trial, NCT05081128) used a placebo (sham) valve setting to rigorously test whether shunting truly works — landmark evidence confirming the gait benefit.
- Research is improving imaging and biomarker predictors (refining DESH, callosal angle, and combining them with the tap test) to better select patients.
- Studies of shunt techniques and valve settings, and of rehabilitation after surgery, aim to improve outcomes and reduce complications.
Questions to ask your doctor
- What follow-up will I need after a shunt, and what symptoms should prompt a call?
- If I don't have surgery, how do we keep me safe and functioning?
- How durable is the benefit likely to be in my case?
- Are there clinical trials I might be eligible for?
Support & Resources
Below are specialty centers, support organizations, a note on family planning, a glossary, what does not work, and the sources behind this guide.
Getting the right evaluation
Because NPH is treatable but easily missed, getting to the right specialists matters. Evaluation usually involves a neurologist (often with expertise in movement or cognitive disorders) and a neurosurgeon, ideally at a center experienced in NPH that can perform tap tests, lumbar drainage, and shunt surgery and manage adjustable valves. If walking decline and possible NPH are suspected, ask your doctor for a referral; do not assume that gait and memory changes are simply unavoidable aging.
Living with the bladder and walking symptoms day to day
While pursuing diagnosis and treatment, practical steps ease daily life. For bladder urgency: scheduled bathroom trips, easy-access clothing, a clear and well-lit path to the toilet (and a bedside option at night), and managing fluids sensibly can reduce accidents and the rushed trips that cause falls; ask about treatments for overactive bladder, but be aware some bladder medicines can affect thinking, so choices should be made with the cognitive picture in mind. For walking: use a properly fitted cane or walker if recommended, take time turning (a common moment for falls), and keep moving safely to maintain strength. For thinking: routines, reminders, and reducing clutter and distractions help. These measures are valuable both before treatment and for anyone who does not have surgery, and they preserve dignity and independence while the bigger decisions are made.
For caregivers
Caregivers are central to recognizing NPH and supporting treatment. Some of the most valuable help: notice and describe the pattern (especially walking changes and falls), keep notes and even short videos of the gait to show the team, get to appointments and the tests that require timing and observation, support safety at home (reduce fall hazards, manage the bladder symptoms with dignity), and after surgery help with physical therapy and watch for warning signs (new or positional headaches, increasing confusion). Encourage independence and patience — recovery of walking can take time — and look after your own wellbeing too.
Two contributions from caregivers are especially powerful. First, recognition: families often notice the gradual walking decline and falls before anyone names NPH, and raising the question — “could this be treatable normal pressure hydrocephalus?” — can set the whole evaluation in motion. A short phone video of the person walking and turning, taken before and again after a tap test, is genuinely useful objective evidence for the team. Second, vigilance after surgery: knowing the warning signs of shunt problems (new or worse headache especially when upright, increasing confusion or sleepiness, fever with a stiff neck, or a return of symptoms) and acting on them promptly can prevent serious complications. Beyond these, the everyday support — getting to appointments, encouraging therapy, keeping the home safe — carries the recovery. And caregivers should protect their own health and seek support; this is a demanding role, and resources exist for you as well.
A note on family planning
Idiopathic NPH is a condition of older adults, so pregnancy is rarely relevant to it. (Hydrocephalus from other causes can occur in younger people, and management of CSF shunts in pregnancy is a specialized topic handled by the neurosurgery and obstetric teams.) For the typical older patient with iNPH, the practical priorities are mobility, fall prevention, and cognition rather than reproductive considerations.
Mountain West / Utah
- University of Utah Health — Neurosurgery and Neurology (Salt Lake City): evaluation for NPH including tap testing, lumbar drainage, and shunt surgery with adjustable valves; appointments via University of Utah Health (801-585-7575).
- Intermountain Health neurosciences — neurology and neurosurgery services across the Wasatch Front and Intermountain West.
- George E. Wahlen VA Medical Center (Salt Lake City) — neurology and neurosurgery for eligible veterans.
- Physical therapy and fall-prevention programs — important before and after treatment.
Making the decision well
Deciding whether to have a shunt is a personal choice best made with clear information and the right team. Helpful steps: ask for your objective results — how much your walking improved with the tap test, and what your imaging shows — since these drive the odds of benefit. Ask which of your symptoms are most likely to improve and which may not, and what the specific risks are for you. Consider a second opinion at an experienced NPH center if you are unsure. Weigh the potential gains (especially regaining safer, more independent walking and reducing falls) against the surgical risks and your overall health and goals. Bring a family member to appointments, write down questions, and take the time you need — while remembering that treating earlier, before symptoms are severe and long-standing, tends to give better results. There is rarely a single “right” answer; the goal is a decision that fits your situation and values.
Finding an experienced center
Outcomes in NPH depend heavily on careful selection and an experienced team, so where you are evaluated matters. Look for a center that can do the full workup — neurology and neurosurgery working together, with the ability to perform a tap test and extended lumbar drainage, supportive imaging interpretation, objective gait assessment, and shunt surgery with adjustable-valve management and good follow-up. Academic medical centers, comprehensive neuroscience programs, and hospitals recognized for hydrocephalus care are good places to start; the Hydrocephalus Association maintains resources and can help you locate experienced programs. If your initial evaluation is uncertain or you are told nothing can be done, a second opinion at such a center is reasonable, because the difference between a thorough and a cursory workup can be the difference between missing and finding a treatable condition.
National organizations
- Hydrocephalus Association (hydroassoc.org) — NPH-specific education, support, a helpline, and a center-locator; a leading resource for patients and families.
- National Institute of Neurological Disorders and Stroke (NINDS) (ninds.nih.gov) — trustworthy information on NPH.
- American Association of Neurological Surgeons (AANS) patient information (aans.org).
- ClinicalTrials.gov — searchable registry of NPH studies.
International access
NPH is recognized and treated worldwide, and shunt surgery is widely available in countries with neurosurgical care. The condition has been especially studied in Japan, which has published detailed national guidelines for iNPH, and international guidelines (developed with groups including the Hydrocephalus Association) and the American Academy of Neurology practice guideline inform care globally. Access to advanced diagnostic testing (lumbar drainage, infusion studies) and to experienced NPH centers varies by region; where specialized care is limited, the priority is recognizing the condition and referring to a center that can perform proper selection and surgery.
The core approach is similar across countries: recognize the gait-predominant syndrome with enlarged ventricles, confirm a response to removing fluid, and offer shunting to well-selected patients. Some differences exist — for example, lumboperitoneal shunting (draining from the lower spine rather than the brain) is used more commonly in Japan, and the availability of the most advanced diagnostic tests and adjustable-valve technology differs by health system. Wherever you are, the most important steps are the same and within reach: have the possibility of NPH considered when walking decline is unexplained, get to a center that can do a proper workup, and weigh treatment based on your individual response to the tap test and your overall health. The transformation a shunt can bring to walking applies regardless of country, for the right patient.
Using organizations and information wisely
The organizations listed here offer more than information: the Hydrocephalus Association in particular provides NPH-specific education, a helpline, peer support, and help locating experienced centers — valuable because NPH care depends so much on getting to the right team. When researching online, favor established, non-commercial sources (the organizations here, the NIH/NINDS, and major academic centers), and be skeptical of anything promising a quick cure or a non-surgical “fix,” since the only treatment with proven benefit is shunting in selected patients. Bring what you read — especially about tests, surgery, or trials — to your own neurologist or neurosurgeon to check how it applies to your situation. A trusted specialist plus a reputable patient organization is usually the best combination, giving you both expert, individualized guidance and the practical, lived-experience support that helps families navigate the journey.
What does not work
Being clear about ineffective approaches prevents wasted effort and false hope. Medications do not reliably treat NPH — drugs such as acetazolamide have been tried to reduce CSF production but are not an effective or durable treatment. Repeated spinal taps are useful for diagnosis (the tap test) but are not a long-term treatment. Endoscopic third ventriculostomy (ETV), a surgery effective for some other forms of hydrocephalus, is generally not effective for idiopathic NPH. And no supplement or alternative therapy treats NPH. The one intervention with proven benefit is CSF shunting in appropriately selected patients.
Key sources
Based on the American Academy of Neurology practice guideline on iNPH (response to shunting and predictors of response); international and Japanese iNPH guidelines; the PENS pilot (NCT03350750) and PENS efficacy (NCT05081128) placebo-controlled shunting trials, published in 2025; standard neurosurgical and neurology references on diagnosis (Evans index, DESH, tap test, lumbar drainage) and treatment; and ClinicalTrials.gov registry data. This guide is educational and is not a substitute for advice from your own medical and surgical team.